651 related articles for article (PubMed ID: 28156207)
1. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
[TBL] [Abstract][Full Text] [Related]
2. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
Park DK; Kim SS; Thakur N; Boden SD
Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
[TBL] [Abstract][Full Text] [Related]
4. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
[TBL] [Abstract][Full Text] [Related]
5. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of rhBMP-2 versus iliac crest bone graft for posterior C1-C2 fusion in patients older than 60 years.
Yan L; Chang Z; He B; Liu T; Wang X; Guo H; Hao D
Orthopedics; 2014 Jan; 37(1):e51-7. PubMed ID: 24683657
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
[TBL] [Abstract][Full Text] [Related]
8. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion.
Sandhu HS; Toth JM; Diwan AD; Seim HB; Kanim LE; Kabo JM; Turner AS
Spine (Phila Pa 1976); 2002 Mar; 27(6):567-75. PubMed ID: 11884903
[TBL] [Abstract][Full Text] [Related]
9. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
10. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
Glassman SD; Dimar JR; Carreon LY; Campbell MJ; Puno RM; Johnson JR
Spine (Phila Pa 1976); 2005 Aug; 30(15):1694-8. PubMed ID: 16094268
[TBL] [Abstract][Full Text] [Related]
11. The effect of vancomycin powder on bone healing in a rat spinal rhBMP-2 model.
Mendoza MC; Sonn KA; Kannan AS; Bellary SS; Mitchell SM; Singh G; Park C; Yun C; Stock SR; Hsu EL; Hsu WK
J Neurosurg Spine; 2016 Aug; 25(2):147-53. PubMed ID: 27035510
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
13. Heterotopic ossification following single-level anterior cervical discectomy and fusion: results from the prospective, multicenter, historically controlled trial comparing allograft to an optimized dose of rhBMP-2.
Arnold PM; Anderson KK; Selim A; Dryer RF; Kenneth Burkus J
J Neurosurg Spine; 2016 Sep; 25(3):292-302. PubMed ID: 27129045
[TBL] [Abstract][Full Text] [Related]
14. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years.
Singh K; Smucker JD; Gill S; Boden SD
J Spinal Disord Tech; 2006 Aug; 19(6):416-23. PubMed ID: 16891977
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
[TBL] [Abstract][Full Text] [Related]
17. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of age: a cost-utility study.
Carreon LY; Glassman SD; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine (Phila Pa 1976); 2009 Feb; 34(3):238-43. PubMed ID: 19179918
[TBL] [Abstract][Full Text] [Related]
18. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
[TBL] [Abstract][Full Text] [Related]
19. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
[TBL] [Abstract][Full Text] [Related]
20. Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis.
Singh K; Dumonski M; Stanley T; Ponnappan R; Phillips FM
Spine (Phila Pa 1976); 2011 Feb; 36(3):192-6. PubMed ID: 20634780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
